SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies (BMNR) is generating significant buzz following its shareholder meeting, where the approval of a substantial increase in authorized shares and a strategic investment in a prominent content creator's company have sparked intense debate. The community is sharply divided, with many expressing concerns over potential dilution and the strategic rationale of the new investment, while others view these moves as a visionary play to expand reach and diversify beyond its core Ethereum holdings. This divergence in opinion, alongside the stock's performance relative to Ethereum, continues to fuel active discussion.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood ($HOOD) is seeing intense conversation following news of indefinitely delayed U.S. crypto legislation, which its CEO suggests negatively impacts American customers and has led to a significant stock decline. This, along with notices of planned future insider share sales, fuels bearish speculation about the company's valuation and near-term price action among some traders. However, a strong bullish contingent points to robust revenue growth and the booming success of prediction markets as key drivers, framing the current dip as a compelling buying opportunity.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile (ASTS) is soaring to new all-time highs, definitively closing above $100 for the first time, driven by reports of a recent satellite breakthrough. Long-term investors are celebrating this major milestone and anticipating further gains, contrasting sharply with persistent bearish sentiment challenging the pre-revenue valuation and potential need for more capital. Community dialogue highlights the critical need for ASTS's direct-to-cell satellite connectivity, underscored by recent telecom outages, and speculates on upcoming launches and government contract catalysts.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings Ltd (SPHL) is trending following an explosive price surge, driven by its ultra-low share float and strong short squeeze potential. The trading community is actively discussing substantial gains and comparing SPHL to other recent high-volatility micro-cap runners, alongside frustrations over some brokers restricting trading activity.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is trending following its recent 1-for-15 reverse stock split, which created an ultra-low share float. This has ignited significant community discussion and speculation about a potential short squeeze, drawing comparisons to other high-volatility, low-float runners like $SPHL. Despite some frustration over frequent trading halts, investors are actively discussing its potential for substantial upward price movement.

TryHard Holdings Ltd. is a lifestyle entertainment company that operates in Japan offering a diverse range of services across the entertainment and hospitality sectors. It operates through the following business segments: Consultancy and management, Event curation, Sub-leasing and Restaurants. The Consultancy and management segment provides expert services to clubs, including operations, event management, and strategic support to enhance performance and engagement. The Event curation segment organize and produce own events, also provides a full suite of services, including event planning, construction, entertainment booking, event operation, and ticket sales. The Sub-Leasing segment acts as an intermediary between landlords and clubs. The Restaurants segment operates several restaurants. The company was founded on October 16, 2013 and is headquartered in Osaka, Japan.

TryHard Holdings Ltd.

TryHard Holdings (THH) is actively trending as a recent IPO with significant volatility, fueled by announcements of a substantial equity purchase facility and a share repurchase program. The community is sharply divided, with many anticipating a major rebound or squeeze due to its low float, while others caution about it being a high-risk pump-and-dump, referencing patterns often seen with similar foreign-based offerings.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials is a trending topic following its recent IPO, with community discussion centered on its extremely low float of 1.25 million shares and a 180-day insider lock-up period, creating a strong short squeeze narrative. Many investors are anticipating significant price action, driven by recent patent news for its GelrinC product and expectations for further company updates.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

Structure Therapeutics (GPCR) is trending after releasing positive Phase 2b data for its oral GLP-1 receptor agonist, aleniglipron, demonstrating significant weight loss. The community is buzzing with speculation about a potential acquisition, especially given recent M&A activity in the competitive obesity drug sector. Investors are weighing the drug's efficacy and tolerability profile against rival therapies as a potential takeover target.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid significant market volatility following its $7.75 billion all-cash acquisition of cybersecurity firm Armis and a notable analyst downgrade, intensifying concerns about AI's impact on the broader software sector. The stock has seen a sharp decline, leading to widespread community debate; many are frustrated by the persistent sell-off, while others view the current valuation as a compelling long-term buying opportunity for a high-quality company strategically positioned to integrate AI. Investors are actively discussing whether the market is overreacting to disruption fears, overlooking ServiceNow's core strengths and its potential to leverage AI for future growth.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is a key focus for investors following recent ERCOT approval that doubled its Helios data center's power capacity to over 1.6 gigawatts, cementing its position as a significant AI infrastructure provider. The community is keenly discussing the massive revenue potential from new multi-tenant partnerships and a re-rating of the stock as the market increasingly recognizes its AI capabilities beyond its traditional crypto identity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced multiple business updates and progress on the Company's neurological and rare disease drug candidates, which will be discussed today during...

Wall Street Jolted By Trump-Fed Fight  Bloomberg Businessweek Daily 1/12/2026

On today's episode of Bloomberg Businessweek Daily, Tim Stenovec and Emily Graffeo discuss market reaction to the DOJ's subpoena of the Federal Reserve. Bloomberg's Enda Curran and Michael...

FTRE vs. ACAD: Which Stock Is the Better Value Option?

Wall Street Zen Upgrades ACADIA Pharmaceuticals (NASDAQ:ACAD) to "Buy"

Wall Street Zen upgraded shares of ACADIA Pharmaceuticals from a "hold" rating to a "buy" rating in a research note on Sunday...

ACADIA Pharmaceuticals Inc. $ACAD Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC increased its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 21.9% in the third quarter, according to its most recent filing with the...

ACADIA Pharmaceuticals (NASDAQ:ACAD) Cut to "Hold" at Wall Street Zen

Wall Street Zen downgraded shares of ACADIA Pharmaceuticals from a "buy" rating to a "hold" rating in a research report on Saturday...

Rice Hall James & Associates LLC Sells 54,869 Shares of ACADIA Pharmaceuticals Inc. $ACAD

Rice Hall James & Associates LLC reduced its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 8.2% in the 3rd quarter, according to its most recent filing with the...

ACADIA Pharmaceuticals Inc. $ACAD Holdings Decreased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. trimmed its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 98.4% during the 3rd quarter, according to its most recent disclosure with...

ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Here's Why

ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Should You Buy...

Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Acadia Pharmaceuticals Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

ACAD
Acadia Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ACAD News

ACADAcadia Pharmaceuticals Inc